Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®.
Nagaendran KandiahPaulus Anam OngTurana YudaLi-Ling NgKaysar MamunReshma Aziz MerchantChristopher ChenJacqueline DominguezSimeon MarasiganEncarnita AmpilVan Thong NguyenSuraya YusoffYee Fai ChanFee Mann YongOrapitchaya KrairitChuthamanee SuthisisangVorapun SenanarongYong JiRamesh ThukralRalf IhlPublished in: CNS neuroscience & therapeutics (2020)
The Expert Group foresee an important role for EGb 761® , used alone or as an add-on therapy, in the treatment of MCI and dementias, particularly when patients do not derive benefit from acetylcholinesterase inhibitors or NMDA antagonists. EGb 761® should be used in alignment with local clinical practice guidelines.